U.S. FDA approves Gilead's blood cancer drug Zydelig
July 23, 2014 at 12:05 PM EDT
July 23 (Reuters) - The U.S. Food and Drug Administration has approved Gilead Inc's drug Zydelig to treat three types of blood cancer, the agency said on Wednesday.
